A lower initial lung diffusion capacity for carbon monoxide is associated with a higher rate of progression from very early diagnosis to definite systemic sclerosis.
People with interstitial lung diseases who use supplemental oxygen are more than three times as likely to have pulmonary ...
Specific combinations of CT imaging features rather than individual findings alone may improve the accuracy of identifying ...
For its 2nd anniversary, Callisto DataHub offers free annotated datasets of 50 suspected lung cancer X-rays and 50 ...
BOSTON, March 25, 2026 (GLOBE NEWSWIRE)-- Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm ...
Familial pulmonary fibrosis (FPF) is increasingly recognized as a distinct entity within the spectrum of interstitial lung diseases (ILDs), characterized by a significant genetic contribution ...
ABSTRACT: Interstitial lung disease (ILD) is the primary pulmonary complication leading to disability and mortality in patients with systemic autoimmune rheumatic diseases (SARDs), particularly ...
ABSTRACT: Interstitial lung disease (ILD) is the primary pulmonary complication leading to disability and mortality in patients with systemic autoimmune rheumatic diseases (SARDs), particularly ...
Chen has previously received speaker fees from Boehringer Ingelheim. Troy has received speaker fees from Boehringer Ingelheim and Erbe; consultancy fees from Moderna and Boehringer Ingelheim; ...
Credit: Getty Images The ATS/ERS 2025 statement on interstitial pneumonia classification, an update of the 2013 statement, reflects new thinking on IP, PPF, molecular pathology, and treatments. The ...
Introduction Interstitial lung diseases (ILDs) are a heterogeneous group of diseases characterised by varying degrees of inflammation and fibrosis. Among these, fibrotic interstitial lung disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results